Literature DB >> 21296901

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.

Stefan M Gold1, Schulamith Krüger, Kristin J Ziegler, Thorsten Krieger, Karl-Heinz Schulz, Christian Otte, Christoph Heesen.   

Abstract

OBJECTIVE: Depression and fatigue are among the most common symptoms of multiple sclerosis (MS). These symptoms frequently co-occur and partially overlap in MS but their underlying biological substrates are unclear. In this study, the relative role of cytokines and hypothalamic-pituitary-adrenal (HPA) axis activity in depression and fatigue were examined in patients with relapsing-remitting MS (RRMS).
METHODS: HPA axis function and frequency of stimulated cytokine (interferon γ (IFNγ) and tumour necrosis factor α (TNFα)) producing T cells was measured cross sectionally in 44 female patients with RRMS. All subjects completed a neurological examination, the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and self-report questionnaires.
RESULTS: 10 patients met diagnostic criteria for major depressive disorder (MDD). MS patients with comorbid MDD showed normal morning but elevated evening salivary cortisol levels, resulting in a flattened slope. While a higher frequency of cytokine producing CD8+ T cells was also seen in MS patients with MDD, these markers were more closely associated with fatigue than depression.
CONCLUSIONS: This study supports a role for HPA axis hyperactivity in major depression in MS. In addition, inflammatory and neuroendocrine factors may differentially mediate fatigue and depressive symptoms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296901     DOI: 10.1136/jnnp.2010.230029

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 2.  Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes?

Authors:  Michelle L Byrne; Neil M O'Brien-Simpson; Sarah A Mitchell; Nicholas B Allen
Journal:  Child Psychiatry Hum Dev       Date:  2015-12

3.  Depression and Anxiety are Common in Acute HIV Infection and Associate with Plasma Immune Activation.

Authors:  Joanna Hellmuth; Donn Colby; Victor Valcour; Duanghathai Suttichom; Serena Spudich; Jintanat Ananworanich; Peeriya Prueksakaew; Napapon Sailasuta; Isabel Allen; Linda L Jagodzinski; Bonnie Slike; Derek Ochi; Robert Paul
Journal:  AIDS Behav       Date:  2017-11

4.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 5.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 6.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

Review 7.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

8.  Serum interleukin 6 levels are associated with depressive state of the patients with knee osteoarthritis irrespective of disease severity.

Authors:  Yukio Shimura; Hisashi Kurosawa; Masaru Tsuchiya; Mamiko Sawa; Haruka Kaneko; Lizu Liu; Yuji Makino; Hidetoshi Nojiri; Yoshiyuki Iwase; Kazuo Kaneko; Muneaki Ishijima
Journal:  Clin Rheumatol       Date:  2017-09-12       Impact factor: 2.980

9.  Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Authors:  Stefan M Gold; Mary-Frances O'Connor; Raja Gill; Kyle C Kern; Yonggang Shi; Roland G Henry; Daniel Pelletier; David C Mohr; Nancy L Sicotte
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

Review 10.  Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Authors:  Claudio Solaro; Giulia Gamberini; Fabio Giuseppe Masuccio
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.